Puma Biotechnology Inc expected to post earnings of 1 cent a share - Earnings Preview

Puma Biotechnology

02/08/2023 03:06

* Puma Biotechnology Inc  PBYI.OQ   PBYI.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 3. 
    * The Los Angeles California-based  company is expected to
report 
a 13.1% decrease in revenue to $51.733 million from $59.52
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Puma Biotechnology
Inc is
for earnings of 1 cent per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $4.5​, above​ its last closing price
of $3.55. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.07       -0.07      0.03      Beat    142.9
 Dec. 31 2023  0.05        0.05       -0.12     Missed  -340
 Sep. 30 2022  -0.06       -0.05      -0.01     Beat    81.8​
 Jun. 30 2022  0.01        0.01       0.21      Beat    1,958.
                                                        8
 ​​Mar.        -0.16       -0.17      -0.08     Beat    51.8
 31 2022                                                
 Dec. 31 2021  -0.08       -0.09      0.10      Beat    214.2​
 Sep. 30 2021  -0.32       -0.31      -0.90     Missed  -188.8
 Jun. 30 2021  -0.25       -0.27      -0.13     Beat    52.1
 This summary was machine generated August 2 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated